Key Laboratory of Neuroregeneration of Jiangsu and the Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong226001, China.
Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong226001, China.
Rev Neurosci. 2021 Feb 10;32(5):545-558. doi: 10.1515/revneuro-2020-0121. Print 2021 Jul 27.
Clinical therapies for chronic pain are limited. While targeted drugs are promising therapies for chronic pain, they exhibit insufficient efficacy and poor targeting. The occurrence of chronic pain partly results from central changes caused by alterations in neurons in the rostral ventromedial medulla (RVM) in the brainstem regulatory pathway. The RVM, which plays a key role in the descending pain control pathway, greatly contributes to the development and maintenance of pain. However, the exact roles of the RVM in chronic pain remain unclear, making it difficult to develop new drugs targeting the RVM and related pathways. Here, we first discuss the roles of the RVM and related circuits in chronic pain. Then, we analyze synaptic transmission between RVM neurons and spinal cord neurons, specifically focusing on the release of neurotransmitters, to explore the cellular mechanisms by which the RVM regulates chronic pain. Finally, we propose some ideas for the development of drugs targeting the RVM.
慢性疼痛的临床治疗方法有限。虽然靶向药物是治疗慢性疼痛的有前途的疗法,但它们表现出疗效不足和靶向性差。慢性疼痛的发生部分是由于脑干调节途径中延髓头端腹内侧核(RVM)神经元的变化引起的中枢变化。RVM 在下行疼痛控制途径中发挥关键作用,极大地促进了疼痛的发展和维持。然而,RVM 在慢性疼痛中的确切作用尚不清楚,因此难以开发针对 RVM 及相关途径的新药。在这里,我们首先讨论 RVM 及相关回路在慢性疼痛中的作用。然后,我们分析 RVM 神经元和脊髓神经元之间的突触传递,特别是专注于神经递质的释放,以探讨 RVM 调节慢性疼痛的细胞机制。最后,我们提出了一些针对 RVM 药物开发的思路。